FindTrial
Sign In

study on comparing drug response of bupivacaine with dexmedetomidine and levobupivacaine with dexmedetomidine(drug name)in spinal anaesthesia for lower limb surgeries-A Randomised Controlled trial

comparative study between intrathecal 0.5% Levobupivacaine with Dexmedetomidine and intrathecal 0.5% Bupivacaine with Dexmedetomidine in elective infraumbilical surgeries-A prospective double blinded Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049787
Enrollment
60
Registered
2023-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: G00-G99- Diseases of the nervous system

Interventions

Intervention1: Subarachnoid block: comparison of onset and duration of sensory and motor blockade between 0.5% levobupivacaine with 50mcg dexmedetomidine and 0.5%bupivacaine with 50mcg dexmedetomidine

Sponsors

Chowndharrya Soccalingame
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18to60yrs American society of anaesthesiologists class 1 and 2 Patient undergoing elective infraumbilical surgeries

Exclusion criteria

Exclusion criteria: Contraindications for neuraxial blockade Patient converted to general anaesthesia Any psychiatric illness or on antipsychotic medications

Design outcomes

Primary

MeasureTime frame
O.5%levobupivacaine with 50mcg dexmedetomidine will show onset and prolonged duration of sensory and motor blockade than 0.5%bupivacaine with dexmedetomidine in subarachnoid BlockTimepoint: Sensory blockade will be assessed by 3point qualitative scale,motor blockade assessed by 3point qualitative scale, Post operative pain assessed by visual analogue scale at 0min,3min,6min,9min,12min,15min,30min,45min,60min,90min,120min,6hrs,12hrs,24hrs—

Secondary

MeasureTime frame
O.5%bupivacaine with 50mcg dexmedetomidine will show lesser onset and duration of sensory and motor blockade than 0.5%levobupivacaine with 50mcg dexmedetomidine in subarachnoid blockTimepoint: Sensory blockade will be assessed by 3point qualitative scale,motor blockade assessed by 3point qualitative scale, Post operative pain assessed by visual analogue scale at 0min,3min,6min,9min,12min,15min,30min,45min,60min,90min,120min,6hrs,12hrs,24hrs—

Countries

India

Contacts

Public ContactChinthavali Sujatha

Sri Venkateshwaraa Medical College Hospital and Research Centre

sujathachinthavali@gmail.com8939012490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026